This process is mediated through the upregulation of SOCS5, a target of LINC01119, which further drives macrophage polarization and immune evasion, ultimately supporting tumor progression and immune resistance in ovarian cancer (122). This evidence concerns the gene LINC01118 and ovarian carcinoma.